Exagen (XGN) Gains from Investment Securities (2018 - 2026)

Exagen (XGN) has reported Gains from Investment Securities for 9 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.

• Gains from Investment Securities for Q1 2026 came in at $100000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 762.27% YoY), and the FY2025 annual result was -$792000.0, down 104.65% from the prior year.
• Gains from Investment Securities was $100000.0 for Q1 2026 at Exagen, up from -$645000.0 in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $2.7 million in Q3 2025 and troughed at -$645000.0 in Q4 2025.
• Average Gains from Investment Securities over 5 years is $278000.0, with a median of $100000.0 recorded in 2026.
• The widest YoY moves for Gains from Investment Securities: up 1346.15% in 2022, down 231.82% in 2022.
• Over 5 years, Gains from Investment Securities stood at $641000.0 in 2022, then slipped by 9.98% to $577000.0 in 2023, then plunged by 167.07% to -$387000.0 in 2024, then sank by 66.67% to -$645000.0 in 2025, then jumped by 115.5% to $100000.0 in 2026.
• Per Business Quant data, the three most recent Gains from Investment Securities figures were $100000.0 in Q1 2026, -$645000.0 in Q4 2025, and $2.7 million in Q3 2025.